A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Absci Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 238,800 shares of ABSI stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
238,800
Previous 49,900 378.56%
Holding current value
$1.02 Million
Previous $283,000 159.72%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $551,588 - $1.24 Million
188,900 Added 378.56%
238,800 $735,000
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $170,159 - $286,426
49,900 New
49,900 $283,000
Q1 2023

May 15, 2023

SELL
$1.58 - $3.41 $790 - $1,705
-500 Reduced 4.67%
10,200 $17,000
Q4 2022

Feb 14, 2023

SELL
$2.0 - $3.58 $200 - $358
-100 Reduced 0.93%
10,700 $22,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $31,860 - $52,164
10,800 New
10,800 $34,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $397M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.